Management Buy-Out at Mohs Klinieken
Management Buy-Out | Healthcare & Education
Transaction
Dr. J.M. Muche, dermatologist at Mohs Klinieken, and his colleague Drs. A. van Rengen, have acquired 100% of the shares in Mohs Holding B.V. by means of a Mangement Buy-Out. Rembrandt Mergers & Acquisitions assisted the management team in realizing this Mangement Buy-Out.
Mohs Holding B.V.
Mohs Klinieken has locations in Dordrecht, Amsterdam and Hoorn and is, besides practicing general dermatology, one the few Dutch clinics with a specialism in Mohs technique for derma-oncology (skin cancer). This is a highly innovative technique that, in comparison to the traditional treatment of skin cancer, significantly increases the success rate of skin cancer operations. Founded eight years ago, Mohs Klinieken has become a leading and innovative player in dermatological care. More information is available at: www.mohsklinieken.nl
The management team
The management team has been involved in Mohs Klinieken for a long time and already held a minority stake in the company. By means of the Management Buy-Out, they have been able to realize their ambition of becoming the joint owners of the company.
Dr. J.M. Muche, dermatologist at Mohs Klinieken, and his colleague Drs. A. van Rengen, have acquired 100% of the shares in Mohs Holding B.V. by means of a Mangement Buy-Out. Rembrandt Mergers & Acquisitions assisted the management team in realizing this Mangement Buy-Out.
Mohs Holding B.V.
Mohs Klinieken has locations in Dordrecht, Amsterdam and Hoorn and is, besides practicing general dermatology, one the few Dutch clinics with a specialism in Mohs technique for derma-oncology (skin cancer). This is a highly innovative technique that, in comparison to the traditional treatment of skin cancer, significantly increases the success rate of skin cancer operations. Founded eight years ago, Mohs Klinieken has become a leading and innovative player in dermatological care. More information is available at: www.mohsklinieken.nl
The management team
The management team has been involved in Mohs Klinieken for a long time and already held a minority stake in the company. By means of the Management Buy-Out, they have been able to realize their ambition of becoming the joint owners of the company.
